@article{schramm2026_115551,
  title = {Accessing the Digital Health Application (DiGA) Market : Key Success Factors, Market Barriers and Strategies for Sustainable Adoption},
  author = {Schramm, Luka and Cebulla, Nadine and Greis, Christian and Carbon, Claus-Christian},
  year = {2026},
  pages = {1-15},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-115551x},
  url = {https://fis.uni-bamberg.de/handle/uniba/115551},
  language = {eng},
  abstract = {Although the digital health application (DiGA) market in Germany offers great opportunities for developing powerful digital applications, it has also faced substantial challenges. DiGA are evidence-based digital interventions in Germany that have been established as reimbursable solutions. This initiative is being copied in other European countries, which have introduced similar pathways. This study systematically identifies and assesses key success factors, marketing and sales strategies and critical DiGA components affecting DiGA adoption. A mixed-methods approach was applied, combining semi-structured expert interviews (n = 32) with a quantitative survey (n = 142) among DiGA manufacturers, healthcare professionals, and industry experts. Statistical comparisons between high prescription volumes (>15 000), moderate prescription volumes (2000-15 000) and low prescription volumes (<2000) DiGA manufacturers were conducted to determine significant differences in factor scoring. The findings highlight three core drivers of DiGA success: robust clinical evidence, access to the right physicians, and awareness at the point of care. High regulatory burdens, the DiGA prescription process, and physicians’ unawareness were identified as the greatest barriers to adoption. The indication-specific nature of DiGA success was evident, emphasizing the need for tailored go-to-market strategies. This study provides the first structured and data-driven analysis of DiGA commercialization success factors and major challenges. The results offer strategic guidance for manufacturers, emphasizing strategic prescriber access and regulatory adaptation as key enablers of sustainable adoption. Future research should further explore indication-specific strategies, regulatory impact assessments, and international validation to enhance DiGA scalability and integration into healthcare systems.},
  keywords = {digital health, DiGA, digital supply act, digital health applications, digital therapeutics, mHealth, ehealth, entrepreneur, leadership, DTx, success, digitalization}
}

@article{schramm2026_115548,
  title = {Accessing the Digital Health Application (DiGA) Market : Key Success Factors, Market Barriers and Strategies for Sustainable Adoption},
  author = {Schramm, Lukas and Cebulla, Nadine and Greis, Christian and Carbon, Claus-Christian},
  year = {2026},
  journal = {Inquiry : the journal of health care organization, provision and financing},
  volume = {63},
  pages = {1-15},
  publisher = {Sage Publ.},
  address = {Thousand Oaks, Calif.},
  issn = {1945-7243},
  doi = {10.1177/00469580261433432},
  url = {https://fis.uni-bamberg.de/handle/uniba/115548},
  language = {eng},
  abstract = {Although the digital health application (DiGA) market in Germany offers great opportunities for developing powerful digital applications, it has also faced substantial challenges. DiGA are evidence-based digital interventions in Germany that have been established as reimbursable solutions. This initiative is being copied in other European countries, which have introduced similar pathways. This study systematically identifies and assesses key success factors, marketing and sales strategies and critical DiGA components affecting DiGA adoption. A mixed-methods approach was applied, combining semi-structured expert interviews (n = 32) with a quantitative survey (n = 142) among DiGA manufacturers, healthcare professionals, and industry experts. Statistical comparisons between high prescription volumes (>15 000), moderate prescription volumes (2000-15 000) and low prescription volumes (<2000) DiGA manufacturers were conducted to determine significant differences in factor scoring. The findings highlight three core drivers of DiGA success: robust clinical evidence, access to the right physicians, and awareness at the point of care. High regulatory burdens, the DiGA prescription process, and physicians’ unawareness were identified as the greatest barriers to adoption. The indication-specific nature of DiGA success was evident, emphasizing the need for tailored go-to-market strategies. This study provides the first structured and data-driven analysis of DiGA commercialization success factors and major challenges. The results offer strategic guidance for manufacturers, emphasizing strategic prescriber access and regulatory adaptation as key enablers of sustainable adoption. Future research should further explore indication-specific strategies, regulatory impact assessments, and international validation to enhance DiGA scalability and integration into healthcare systems.},
  keywords = {digital health, DiGA, digital supply act, digital health applications, digital therapeutics, mHealth, ehealth, entrepreneur, leadership, DTx, success, digitalization}
}

@article{schramm2024_96582,
  title = {Critical success factors for creating sustainable digital health applications : A systematic review of the German case},
  author = {Schramm, Lukas Elmar and Carbon, Claus-Christian},
  year = {2024},
  pages = {1-14},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-965821},
  url = {https://fis.uni-bamberg.de/handle/uniba/96582},
  language = {eng},
  abstract = {Objective:
The Covid-19 pandemic has accelerated the adoption of digital technologies to address social needs, leading to increased investments in digital healthcare applications. Germany implemented a special law called the “Digitales Versorgungsgesetz” (DVG—Digital Supply Act) in 2019, which enables the reimbursement of digital health applications, including digital therapeutics (DTx), through a fast-track process. The Federal Institute for Drugs and Medical Devices (BfArM), the German federal authority responsible for overseeing digital health applications, has implemented legislative adjustments since the law's introduction, which have increased requirements for these applications and potentially led to the removal of some from the directory as well as a slowdown in the addition of new ones. To counteract this trend, this work aimed to identify key success factors for digital health applications (DiGAs).

Methods:
This research identifies critical success factors through a structured literature review for developing sustainable digital health applications within the European healthcare systems, specifically DiGAs. The study aims to support the ongoing digital transformation in healthcare.

Results:
The identified success factors that significantly impact the sustainability of DiGAs include patient-centered design, application effectiveness, user-friendliness, and adherence to data protection and information security regulations using standardized approaches. These factors are crucial in preventing the failure of DiGA manufacturers in European countries.

Conclusion:
By considering and implementing these critical success factors, DiGA manufacturers can enhance their chances of long-term success and contribute to the digital transformation of the healthcare system in Europe.},
  keywords = {Digital health, DiGA, digital therapeutics, mhealth, ehealth, entrepreneur, leadership, dtx, digitalization}
}

@article{schramm2024_96581,
  title = {Critical success factors for creating sustainable digital health applications : A systematic review of the German case},
  author = {Schramm, Lukas and Carbon, Claus-Christian},
  year = {2024},
  journal = {Digital health},
  volume = {10},
  pages = {1-14},
  publisher = {Sage},
  address = {Thousand Oaks, Calif. [u.a.]},
  issn = {2055-2076},
  doi = {10.1177/20552076241249604},
  url = {https://fis.uni-bamberg.de/handle/uniba/96581},
  language = {eng},
  abstract = {Objective:
The Covid-19 pandemic has accelerated the adoption of digital technologies to address social needs, leading to increased investments in digital healthcare applications. Germany implemented a special law called the “Digitales Versorgungsgesetz” (DVG—Digital Supply Act) in 2019, which enables the reimbursement of digital health applications, including digital therapeutics (DTx), through a fast-track process. The Federal Institute for Drugs and Medical Devices (BfArM), the German federal authority responsible for overseeing digital health applications, has implemented legislative adjustments since the law's introduction, which have increased requirements for these applications and potentially led to the removal of some from the directory as well as a slowdown in the addition of new ones. To counteract this trend, this work aimed to identify key success factors for digital health applications (DiGAs).

Methods:
This research identifies critical success factors through a structured literature review for developing sustainable digital health applications within the European healthcare systems, specifically DiGAs. The study aims to support the ongoing digital transformation in healthcare.

Results:
The identified success factors that significantly impact the sustainability of DiGAs include patient-centered design, application effectiveness, user-friendliness, and adherence to data protection and information security regulations using standardized approaches. These factors are crucial in preventing the failure of DiGA manufacturers in European countries.

Conclusion:
By considering and implementing these critical success factors, DiGA manufacturers can enhance their chances of long-term success and contribute to the digital transformation of the healthcare system in Europe.},
  keywords = {Digital health, DiGA, digital therapeutics, mhealth, ehealth, entrepreneur, leadership, dtx, digitalization}
}

